Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New inhibitors of Aurora kinase A and B presented

Dec. 21, 2010

New inhibitors CK II and/or pim-1 discovered at Cylene Pharma

Dec. 21, 2010

FDA grants fast track status for elacytarabine in AML

Dec. 21, 2010

MRx-102 shows promise in models of AML

Dec. 21, 2010

NS-018 preferentially targets V617F-mutant JAK2

Dec. 21, 2010

Clinical and preclinical data presented on GDC-0941/T-DM1 in HER2+ breast cancer

Dec. 21, 2010

Panobinostat/capecitabine/lapatinib combination is safe in HER2+ breast cancer

Dec. 21, 2010

ClanoTech divulges new inhibitors of VEGFR-2 and VEGFR-3

Dec. 21, 2010

UCB claims new PI3K inhibitors

Dec. 21, 2010

Enzon and NCI begin phase I trials of EZN-2968 and EZN-2208

Dec. 20, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...